Cargando…
Establishment, optimisation and quantitation of a bioluminescent murine infection model of visceral leishmaniasis for systematic vaccine screening
Visceral leishmaniasis is an infectious parasitic disease caused by the protozoan parasites Leishmania donovani and Leishmania infantum. The drugs currently used to treat visceral leishmaniasis suffer from toxicity and the emergence of parasite resistance, and so a better solution would be the devel...
Autores principales: | Ong, Han Boon, Clare, Simon, Roberts, Adam Jonathan, Wilson, Mary Edythe, Wright, Gavin James |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7070049/ https://www.ncbi.nlm.nih.gov/pubmed/32170135 http://dx.doi.org/10.1038/s41598-020-61662-3 |
Ejemplares similares
-
Author Correction: Establishment, optimisation and quantitation of a bioluminescent murine infection model of visceral leishmaniasis for systematic vaccine screening
por: Ong, Han Boon, et al.
Publicado: (2021) -
A chronic bioluminescent model of experimental visceral leishmaniasis for accelerating drug discovery
por: Álvarez-Velilla, Raquel, et al.
Publicado: (2019) -
Nanoliposomal artemisinin for the treatment of murine visceral leishmaniasis
por: Want, Muzamil Y, et al.
Publicado: (2017) -
Quantitative PCR in Epidemiology for Early Detection of Visceral Leishmaniasis Cases in India
por: Sudarshan, Medhavi, et al.
Publicado: (2014) -
NLRP12-expressing dendritic cells mediate both dissemination of infection and adaptive immune responses in visceral leishmaniasis
por: Valadares, Diogo Garcia, et al.
Publicado: (2023)